Viewing Study NCT04675320


Ignite Creation Date: 2025-12-25 @ 4:19 AM
Ignite Modification Date: 2026-02-03 @ 10:22 PM
Study NCT ID: NCT04675320
Status: UNKNOWN
Last Update Posted: 2023-12-07
First Post: 2020-12-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Immuno Monitoring in Patient With Epithelial Ovarian Cancer Eligible to PARP Inhibitors
Sponsor: Centre Georges Francois Leclerc
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Ovarian Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None PARP Inhibitors View
None immunomonitoring View